Topic: manufacturing plant
CDMOs Cambrex and Ajinomoto Bio-Pharma Services upgraded manufacturing plants, Takeda scored an albumin approval via its Shire deal, and more.
Shire’s $1 billion plasma fractionation plant in Georgia has gone through three owners but is now officially open.
Another cell manufacturing facility will be built in the U.S., this by a transatlantic biotech in which GlaxoSmithKline owns a sizable share.
Rubius Therapeutics kicked off a $155 million renovation of a former Alexion facility that was shuttered last year.
Drug manufacturers were shaking off the remnants of Hurricane Florence on Monday after the dangers from the storm morphed into hazardous flooding.
Biopharmaceutical giant Amgen broke ground this week on a $200 million next-generation manufacturing plant located at its West Greenwich, R.I., campus.
Gilead has opened its new $11 million manufacturing facility control lab in Ireland.
Neopharma and ASKA Pharmaceuticals entered a joint venture to build a $53 million pharmaceutical manufacturing facility in India.
Corona Remedies acquired two drug brands from Abbott India and said it plans to invest $11.1 million in building a new manufacturing facility.
Heritage Pharmaceuticals, based in East Brunswick, New Jersey, opened a new manufacturing facility that was built using modular cleanroom walls.